Literature DB >> 19886949

Review article: the gastrointestinal complications of myositis.

E C Ebert1.   

Abstract

BACKGROUND: The inflammatory myopathies are a group of acquired diseases characterized by a proximal myopathy caused by an inflammatory infiltrate of the skeletal muscle. The three major diseases are dermatomyositis, polymyositis and inclusion body myositis. AIMS: To review the gastrointestinal manifestations of myositis.
METHODS: Over 110 articles in the English literature were reviewed.
RESULTS: Dysphagia to solids and liquids occurs in patients with myositis. The pharyngo-oesophageal muscle tone is lost and therefore patients develop nasal speech, hoarseness, nasal regurgitation and aspiration pneumonia. There is tongue weakness, flaccid vocal cords, poor palatal motion and pooling of secretions in the distended hypopharynx. Proximal oesophageal skeletal muscle dysfunction is demonstrated by manometry with low amplitude/absent pharyngeal contractions and decreased upper oesophageal sphincter pressures. Patients exhibit markedly elevated creatine kinase and lactate dehydrogenase levels consistent with muscle injury. Myositis can be associated with inflammatory bowel disease, coeliac disease and interferon treatment of hepatitis C. Corticosteroids and other immunosuppressive drugs comprise the mainstay of treatment. Inclusion body myositis responds poorly to these agents and therefore a myotomy is usually indicated.
CONCLUSION: Myositis mainly involves the skeletal muscles in the upper oesophagus with dysphagia, along with proximal muscle weakness.

Entities:  

Mesh:

Year:  2009        PMID: 19886949     DOI: 10.1111/j.1365-2036.2009.04190.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

2.  Colonic vasculopathy and perforation in the initial presentation of adult dermatomyositis in a patient with improving muscle weakness.

Authors:  Nour Kibbi; Amenuve Bekui; Lenore M Buckley
Journal:  BMJ Case Rep       Date:  2016-01-12

Review 3.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.

Authors:  Keith J Chinniah; Girish M Mody
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

5.  Atypical Presentation of Dysphagia in a Patient Diagnosed Later With Dermatomyositis: A Case Report.

Authors:  Ali Elmdaah; Abuobeida Ali; Zulakha Nadeem; Mohamed Habieb; John Pradeep; Kevin Metangi
Journal:  Cureus       Date:  2021-11-28

6.  Idiopathic spontaneous pneumoperitoneum.

Authors:  Anasua Deb; Binita Ghosh; Annia Cavazos; Busara Songtanin; Natnicha Leelaviwat; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-12-28

7.  [Severe dysphagia and erythrodermia in a 59-year-old man].

Authors:  M A Zuber; M Kouba; S E Rudolph; M Weller; P Hrdlicka
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

Review 8.  Juvenile dermatomyositis resembling late-stage Degos disease with gastrointestinal perforations successfully treated with combination of cyclophosphamide and rituximab: case-based review.

Authors:  William Day; Christos Gabriel; Robert E Kelly; Cynthia M Magro; Judith V Williams; Alice Werner; Laura Gifford; Sameer P Lapsia; Cassyanne L Aguiar
Journal:  Rheumatol Int       Date:  2020-01-03       Impact factor: 2.631

9.  Recurrent pneumatosis intestinalis in a patient with dermatomyositis.

Authors:  Yousef Zarbalian; Erik C von Rosenvinge; William Twadell; Jamal Mikdashi
Journal:  BMJ Case Rep       Date:  2013-08-23

Review 10.  Gastrointestinal motility disorders in neurologic disease.

Authors:  Michael Camilleri
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.